GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Suzhou Highfine Biotech Co Ltd (SZSE:301393) » Definitions » Net Interest Income

Suzhou Highfine Biotech Co (SZSE:301393) Net Interest Income : ¥18.5 Mil (TTM As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Suzhou Highfine Biotech Co Net Interest Income?

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. Suzhou Highfine Biotech Co's net interest income for the three months ended in Mar. 2025 was ¥3.0 Mil. Its net interest income for the trailing twelve months (TTM) ended in Mar. 2025 was ¥18.5 Mil.

Suzhou Highfine Biotech Co Net Interest Income Historical Data

The historical data trend for Suzhou Highfine Biotech Co's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suzhou Highfine Biotech Co Net Interest Income Chart

Suzhou Highfine Biotech Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Interest Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.98 0.57 0.29 27.32 29.48

Suzhou Highfine Biotech Co Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.94 9.59 1.35 4.60 2.96

Suzhou Highfine Biotech Co Net Interest Income Calculation

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors.

Net Interest Income for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥18.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Suzhou Highfine Biotech Co Net Interest Income Related Terms

Thank you for viewing the detailed overview of Suzhou Highfine Biotech Co's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Suzhou Highfine Biotech Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Suzhou Highfine Biotech Co Ltd (SZSE:301393) » Definitions » Net Interest Income
Comparable Companies
SHSE:605199 SHSE:688621 SZSE:301246 SZSE:002793 SZSE:002424 SZSE:002437 SHSE:688566 SZSE:300194 SZSE:002688 SZSE:002349 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
N/A
Address
No. 32 Hongxi Road, F-12 Standard Factory Building, High-tech Zone, Jiangsu Province, Suzhou, CHN, 215151
Website
https://www.highfine.com
Suzhou Highfine Biotech Co Ltd is a high-tech enterprise that provides characteristic raw materials for global pharmaceutical research and development and raw material drug production companies. The products are mainly used in the fields of peptide, nucleotide and pharmaceutical synthesis. The product range covers peptide synthesis reagents for characteristic amide bond formation, molecular building blocks, protein reagents, liposome and lipid nanoparticle pharmaceutical reagents, ionic liquids , PROTAC reagents and nucleotide reagents and other types.
Executives
Dong Sheng Jun Directors, executives
Lu Xue Gen Directors, executives
Lv Min Jie Directors, executives
Xu Jie Directors, executives

Suzhou Highfine Biotech Co Headlines

No Headlines